Literature DB >> 26883704

Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics.

Elizabeth B Hirsch1, Paola C Zucchi2, Alice Chen2, Brian R Raux2, James E Kirby3, Christopher McCoy4, George M Eliopoulos3.   

Abstract

Increasing resistance among Gram-negative uropathogens limits treatment options, and susceptibility data for multidrug-resistant isolates are limited. We assessed the activity of five oral agents against 91 multidrug-resistant Gram-negative urine isolates that were collected from emergency department/hospitalized patients. Fosfomycin and nitrofurantoin were most active (>75% susceptibility). Susceptibilities to sulfamethoxazole-trimethoprim, ciprofloxacin, and ampicillin were ≤40%; empirical use of these agents likely provides inadequate coverage in areas with a high prevalence of multidrug-resistant uropathogens.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26883704      PMCID: PMC4862536          DOI: 10.1128/AAC.02961-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  The emerging threat of multidrug-resistant Gram-negative bacteria in urology.

Authors:  Hosam M Zowawi; Patrick N A Harris; Matthew J Roberts; Paul A Tambyah; Mark A Schembri; M Diletta Pezzani; Deborah A Williamson; David L Paterson
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

Review 2.  Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.

Authors:  K Gupta; T M Hooton; W E Stamm
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

Review 3.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

4.  Emergence of KPC-producing Klebsiella pneumoniae in Texas.

Authors:  Elizabeth B Hirsch; Kai-Tai Chang; Todd M Lasco; Juan-Pablo Caeiro; Vincent H Tam
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

5.  An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae.

Authors:  Elizabeth B Hirsch; Kai-Tai Chang; Paola C Zucchi; Dennis N Francoeur; Kimberly R Ledesma; Vincent H Tam; Todd M Lasco
Journal:  J Infect Chemother       Date:  2013-12-11       Impact factor: 2.211

Review 6.  The epidemiology of urinary tract infection.

Authors:  Betsy Foxman
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

7.  Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.

Authors:  Elizabeth B Hirsch; Brian R Raux; Paola C Zucchi; Yisu Kim; Christopher McCoy; James E Kirby; Sharon B Wright; George M Eliopoulos
Journal:  Int J Antimicrob Agents       Date:  2015-09-30       Impact factor: 5.283

8.  Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and Coresistance phenotype among recent Escherichia coli isolates from U.S. veterans.

Authors:  James R Johnson; Sarah M Drawz; Stephen Porter; Michael A Kuskowski
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

9.  Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota.

Authors:  Sanjeev K Swami; Juliette T Liesinger; Nilay Shah; Larry M Baddour; Ritu Banerjee
Journal:  Mayo Clin Proc       Date:  2012-07-13       Impact factor: 7.616

10.  Antimicrobial resistance and spread of multi drug resistant Escherichia coli isolates collected from nine urology services in the Euregion Meuse-Rhine.

Authors:  Christina F M van der Donk; Jeroen H B van de Bovenkamp; Els I G B De Brauwer; Patrick De Mol; Karl-Heinz Feldhoff; Wiltrud M Kalka-Moll; Sita Nys; Inge Thoelen; Thera A M Trienekens; Ellen E Stobberingh
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more
  3 in total

1.  Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections.

Authors:  Anushree Ulhas Amladi; Baby Abirami; S Manjula Devi; Thambu David Sudarsanam; Subramani Kandasamy; Nitin Kekre; Balaji Veeraraghavan; Rani Diana Sahni
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

2.  Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.

Authors:  Tiffany R Keepers; Marcela Gomez; Chris Celeri; Kevin M Krause; Donald Biek; Ian Critchley
Journal:  Infect Dis Ther       Date:  2017-03-11

3.  Bacteriuria resistance patterns and the suitability of urinalysis as an initial diagnostic tool in a post-antibiotic era.

Authors:  Samih Taktak; Zara Gall; James Dyer
Journal:  Ther Adv Urol       Date:  2021-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.